logo-loader

Trending: DuPont, NightCulture, Pressure BioSciences, Sprint Nextel ...

Last updated: 12:20 26 Jan 2016 EST, First published: 07:20 26 Jan 2016 EST

DuPont

E I Du Pont Nemours – plain old Dupont (NYSE:DD) to thee and me – has reported its first quarterly loss in ages.

What's worse, the loss per share and the revenue numbers were a shade worse than expected. The fourth quarter loss per share was 27 cents, versus expectations of 26 cents a share, while revenue came in at US$5.36bn, versus the median forecast among analysts of US$5.36bn.

Somehow, however, the shares eked out a small rise in early trading.

The intriguingly named Nightculture (OTCBB:NGHT) is the top performer on the OTC market, but why that should be is a mystery, but something appears to be going on because more than half a million shares have traded hands already today.

That pales into insignificance compared to the almost 15mln shares in Saleen Automotive (OTCBB:SLNN) that have been traded, following news yesterday the maker of high performance cars has opened its first international show room in Shanghai, China.

Small cap specialist SeeThruEquity has taken a shine to Pressure BioSciences (OTCQB:PBIO), the pressure cycling medtech company, after the signing of a co-marketing agreement with SCIEX, a big name in life sciences analytical technologies.

“In our view, the strategic sales and marketing partnership with SCIEX is major achievement for PBIO with the potential to be a major catalyst for future sales. During our coverage, PBIO's growth has been restrained by not having enough capital to invest in building a large, skilled sales team with rich industry connections. While not necessarily a panacea for this risk, adding the sales and distribution muscle of a major, worldwide industry partner to PBIO's sales efforts has the potential to be highly impactful,” suggested Ajay Tandon, chief executive of SeeThruEquity.

“We are hopeful that the SCIEX relationship will result in a material increase in and acceleration of PCT's penetration into the market," he added.

The research house has a price target of $1.57 for Pressure BioSciences.

RISERS

SGOCO Group (NASDAQ:SGOC), up 47.1%. BOCA International has authorized a SGOCO subsidiary to exclusively develop and market the BOCA branded energy saving and environmental protection products and technologies in Macau, China.

Comstock Resources (NYSE:CRK), up 38.6%. The company completed an acreage swap with another operator that increases its Haynesville Shale drilling inventory. No cash changed hands.

Sprint Nextel (NYSE:S), up 18.3%. The mobile telecoms company lifted its guidance for the year and proclaimed that its turnaround plan is delivering results.

FALLERS

XTL Biopharmaceuticals (NASDAQ:XTLB), down 41.0%. The company said it had received encouraging feedback from the US Food & Drug Administration concerning its pre-investigational new drug, hCDR1. The share price reaction suggested the feedback was less than encouraging.

Eneroc (NASDAQ:ENOC), down 12.8%. The stock sees profit taking today after yesterday's strong rise on the back of a favourable court ruling for the company.

Polaris Industries (NYSE:PII), down 10.8%. Full year 2015 net income was US$455.4 million, or $6.75 per diluted share, in-line with the company's revised expectations.


 


 


 


 


 


 

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

5 hours, 37 minutes ago